What is the impact of GLP-1 weight loss drugs on MS?
GLP-1 receptor agonists (like Ozempic/semaglutide or Wegovy) are weight loss medications that work by mimicking a natural hormone that helps you feel full, slows digestion, and lowers blood sugar. For people with MS, managing weight matters because a higher BMI is linked Show Full Answer
What is the impact of GLP-1 weight loss drugs on MS?
GLP-1 receptor agonists (like Ozempic/semaglutide or Wegovy) are weight loss medications that work by mimicking a natural hormone that helps you feel full, slows digestion, and lowers blood sugar. For people with MS, managing weight matters because a higher BMI is linked to worse disability and more severe symptoms.
A small study of 33 people with MS taking GLP-1 drugs found they were generally safe and well-tolerated, even among those on disease-modifying therapies (DMTs). No participants had a relapse during the study, though some showed new lesions on MRI scans. Potential side effects to be aware of include:
- Nausea and vomiting
- Reduced appetite
- Diarrhea
- Dizziness
- Headaches
- Indigestion
- Rarely, severe pancreas damage Neurologist Dr. Aaron Boster emphasizes that GLP-1 drugs are not a standalone solution. They work best alongside exercise and healthy lifestyle changes. He also cautions against "yo-yo" weight cycling — losing and regaining weight repeatedly — as that carries its own health risks.
Early research is also exploring whether GLP-1 drugs might help protect or rebuild myelin (the nerve coating damaged in MS), but this is very preliminary with no clinical trials yet.
Always speak with your healthcare team before starting any new medication.
July 13
Join
Your Privacy Choices
